EUVIMEDEUVIMED entdecken
Kohortenstudie

Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study

Yeong Jeong Jeon iD, Kyungdo Han, Seung Woo Lee, Ji Eun Lee, Junhee Park, In Young Cho, Jong Ho Cho iD, Dong Wook Shin

Diseases of the Esophagus · 2024

DOI: 10.1093/dote/doae029 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diseases of the Esophagus, 2024. Verfasst von Yeong Jeong Jeon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Diabetes Mellitus, Type 2, Proportional Hazards Models. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with type 2 diabetes and a developing several cancers including esophageal cancer (EC). However, the association between MASLD and EC in diabetic patients has not been investigated. Therefore, we aimed to investigate the relation between MASLD and developing EC in diabetic patients. This was a population-based retrospective cohort study of data from the Korean National Health Insurance Service (NHIS). A total of 1,904,468 subjects diagnosed with diabetes who underwent NHIS-provided health checkups from 2009 to 2012 were included. We constructed a Cox proportional hazard model for the association of fatty liver index (FLI) and the risk of EC stratified by potential confounders. Over a mean follow-up duration of 6.9 years, the incidence of EC was higher in the high (≥60) FLI group compared to the low (<30) FLI group (14.4 vs. 13.7 event per 100,000 person-years). The risk of EC correlated with the degree of FLI, particularly in older (P = 0.002), female (P = 0.033), non-smoking (P = 0.002), and non-drinking patients (P = 0.025). Among obese patients, the risk of EC was not associated with FLI; however, the risk of EC was higher in the high FLI group in non-obese patients. Lean MASLD patients had the highest risk of EC (adjusted hazard ratio 1.78; 95% confidence interval, 1.5–2.13). MASLD was associated with an increased risk of EC in diabetic patients, and lean MASLD has the highest risk. Further studies are required to determine the causal relationship between MASLD and EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsDiabetes Mellitus, Type 2Proportional Hazards ModelsHumansFemaleMaleMiddle AgedRetrospective StudiesRepublic of KoreaRisk FactorsIncidenceAdultAgedFatty Liver

Stichwörter der Autor:innen

diabetesesophageal cancerfatty liver indexmetabolic dysfunction-associated steatotic liver diseasesquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Statistics and Actuarial Science, Soongsil University, 369 Sangdo-ro, Dongjak-gu, Seoul 06978, Republic of Korea.
  • Department of Biostatistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Family Medicine, Seoul National University Hospital, Seoul.
  • University School of Medicine, Seoul, Republic of Korea.
  • Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Yeong Jeong Jeon, Jong Ho Cho

Zitieren

APA

Jeon, Y. J., Han, K., Lee, S. W., Lee, J. E., Park, J., Cho, I. Y., Cho, J. H., & Shin, D. W. (2024). Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study. Diseases of the Esophagus. https://doi.org/10.1093/dote/doae029

Vancouver

Jeon YJ, Han K, Lee SW, Lee JE, Park J, Cho IY, et al. Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study. Diseases of the Esophagus. 2024. doi:10.1093/dote/doae029

BibTeX
@article{Jeon2024,
  author = {Jeon, Yeong Jeong and Han, Kyungdo and Lee, Seung Woo and Lee, Ji Eun and Park, Junhee and Cho, In Young and Cho, Jong Ho and Shin, Dong Wook},
  title = {Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study},
  journal = {Diseases of the Esophagus},
  year = {2024},
  doi = {10.1093/dote/doae029}
}
Kostenlos starten →